GP Healthcare Capital
14
28M
14
1.56
2
2
- Areas of investment
Summary
In 2015 was created GP Healthcare Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Shanghai. The venture was found in Asia in China.
The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this GP Healthcare Capital performs on 9 percentage points less the average number of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2016. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016.
The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Therapeutics, Medical Device. Among the various public portfolio startups of the fund, we may underline Adagene, MicuRx Pharmaceuticals, Beijing Allcure Medical Technology Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the GP Healthcare Capital, startups are often financed by Morningside Group, WuXi Healthcare Ventures, MAGS Capital. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Trustbridge Partners, TitanMed Capital. In the next rounds fund is usually obtained by Sequoia Capital China, New World TMT Ltd, King Star Capital.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 1.56
- Investments by industry
- Biotechnology (7)
- Health Care (6)
- Medical (4)
- Therapeutics (3)
- Manufacturing (2) Show 12 more
- Investments by region
-
- China (12)
- United States (2)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 0.79
- Avg. company exit year
- 5
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BCC | 15 Jun 2017 | Health Care, Hospital, Medical | Early Stage Venture | 30M | Beijing, Beijing, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.